Breaking News
Sort by:
Top Post
NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition
The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]
ADARx Pharmaceuticals Raises $46 Million in Financing as Lead Product Enters the Clinic
ADARx Pharmaceuticals, a clinical-stage biotechnology company developing RNA-targeting therapeutics, has announced the close of a […]
InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux
InDevR, a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has […]
SoniVie Raises $60m in Round C Financing and Appoints New Board Members
SoniVie, a medical device company developing a proprietary solution to treat hypertension, announced today the […]
Amolyt Pharma Announces $138 Million Series C Financing
Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related […]
Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million
Immune-Onc Therapeutics, a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints has […]
HighTide Therapeutics Raises $107 Million in Series Financing to Advance Innovative Pipeline and Business Collaborations
HighTide Therapeutics, a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and […]
Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital
Onc.AI, a medical technology company developing a novel digital clinical management solution focused on immuno-oncology, […]
Actimed Therapeutics Closes Second Tranche of £10m Seed Financing
Actimed Therapeutics, a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to […]
- Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Read more
- Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read more
- Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Read more
- Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Read more
- Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Read more